Blogs and News
Discover our latest news and blog articles, dedicated to demystifying drug development, medicine, clinical research, and ethics.
How small biotech can overcome clinical trial hurdles
Small biotech companies are responsible for a significant proportion of newly approved medicines, especially for rare diseases. But with limited resources, budget constraints and a lean structure, they face many challenges before they can help patients. Here we look...
Quality assurance – why it’s important and how to do it
Quality assurance is a critical element of a clinical trial, as it ensures the safety of the participants, as well as the reliability and integrity of the documentation and data, and therefore the validity of your results. But what does it entail, when should it happen, and how can you get it right? We share our insights.
Recruitment, decentralization and transparency: a round-up of the latest clinical trial news
With new regulations and guidance promoting transparency, growing calls for better representation, and accelerated developments in technology, the clinical trials landscape is changing continuously. Here is a round-up of the big trends of 2023 so far. At the end of...
Four factors to consider for your cardiovascular clinical trial
Cardiovascular clinical trials are essential in developing interventions like treatments and medical devices for a wide range of cardiovascular diseases. The sheer size and complexity of cardiovascular trials is just one of the factors that make this therapeutic area...
Patient recruitment – how to get (and keep) participants
Finding and enrolling patients can be one of the most challenging aspects of setting up a trial – and even if you reach your recruitment goals, you face the task of retaining those participants for months, years or even decades. But participants are at the heart of...
What to do with negative results clinical research – and why they don’t equal failure
It can be disappointing if your trial generates negative results; you may feel it has been a waste of time and resources. But negative results do not necessarily mean failure.